Non-life insurance has a lot of catching up to do While general insurance in India has seen an 18% CAGR during 2005-14, when compared with global benchmark, its reach is… By Morgan StanleyUpdated: August 11, 2016 16:14 IST
Overweight Sun Pharma on earnings momentum: Morgan Stanley Sun is preparing for the transition to the next level – specialty business; meanwhile, it continues to expand… By Morgan StanleyApril 7, 2015 00:15 IST
Upgrade Reliance Industries to overweight on attractive valuations: Morgan Stanley Upgrade Reliance Industries (RIL) to ‘overweight’ with a price target of R1,062 per share… By Morgan StanleyApril 1, 2015 00:16 IST
Sun Pharma on Asia Pacific Best Ideas list Retain ‘overweight’ on Sun Pharmaceuticals with a target price of R995 per share. By Morgan StanleyUpdated: March 28, 2015 01:23 IST
India vs United Arab Emirates Live Score, Asia Cup 2025: India record their fastest win in the history of T20
Bihar: Centre approves major infra projects worth over Rs 7,000 crore; four-lane highway corridor project greenlit
